VLKIM
Van Lanschot Kempen Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210M | Buy |
517,859
+196,345
| +61% | +$79.6M | 2% | 13 |
|
|
2025
Q1 | $160M | Buy |
321,514
+11,539
| +4% | +$5.74M | 1.67% | 15 |
|
|
2024
Q4 | $161M | Buy |
309,975
+93,425
| +43% | +$48.6M | 1.6% | 13 |
|
|
2024
Q3 | $134M | Buy |
216,550
+3,640
| +2% | +$2.25M | 1.37% | 18 |
|
|
2024
Q2 | $118M | Buy |
212,910
+28,770
| +16% | +$15.9M | 1.32% | 18 |
|
|
2024
Q1 | $107M | Buy |
184,140
+22,622
| +14% | +$13.1M | 1.33% | 17 |
|
|
2023
Q4 | $85.7M | Buy |
161,518
+92,554
| +134% | +$49.1M | 1.2% | 19 |
|
|
2023
Q3 | $34.9M | Buy |
68,964
+2,717
| +4% | +$1.38M | 0.65% | 51 |
|
|
2023
Q2 | $34.6M | Buy |
66,247
+4,763
| +8% | +$2.49M | 0.62% | 59 |
|
|
2023
Q1 | $35.4M | Sell |
61,484
-2,571
| -4% | -$1.48M | 0.67% | 57 |
|
|
2022
Q4 | $35.3M | Buy |
64,055
+38,293
| +149% | +$21.1M | 1.03% | 37 |
|
|
2022
Q3 | $13.1M | Sell |
25,762
-149
| -0.6% | -$75.6K | 0.53% | 68 |
|
|
2022
Q2 | $14.1M | Buy |
25,911
+687
| +3% | +$373K | 0.51% | 73 |
|
|
2022
Q1 | $14.9M | Sell |
25,224
-350
| -1% | -$207K | 0.45% | 79 |
|
|
2021
Q4 | $17.1M | Buy |
25,574
+2,504
| +11% | +$1.67M | 0.53% | 73 |
|
|
2021
Q3 | $13.2M | Buy |
23,070
+6,929
| +43% | +$3.96M | 0.47% | 75 |
|
|
2021
Q2 | $8.14M | Buy |
16,141
+6,862
| +74% | +$3.46M | 0.29% | 93 |
|
|
2021
Q1 | $4.24M | Buy |
9,279
+4,304
| +87% | +$1.96M | 0.19% | 98 |
|
|
2020
Q4 | $2.32M | Buy |
+4,975
| New | +$2.32M | 0.13% | 107 |
|